NutraPlus to manufacture commercial drugs at Tarapur Plant

Published On 2015-08-08 07:44 GMT   |   Update On 2021-08-19 10:52 GMT
Drug firm NutraPlus India will produce its active pharmaceutical ingredient (API) facility at Tarapur plant in Maharashtra

Drug firm NutraPlus India has announced its plans to start the commercial production at its multi-purpose active pharmaceutical ingredient (API) facility at Tarapur plant in Maharashtra from September this year. The API plant has a total installed capacity of 360 MT per annum of various kinds of high-end multi speciality products in therapeutic and analgesic segment of pharma industry, as confirmed by the company to PTI.

"The company will start commercial production from first week of September, 2015 at plant N-92, MIDC Tarapur Maharashtra," NutraPlus India Ltd said in a BSE filing.

The products to be produced at the plant are used by various pharma formulation units to manufacture therapeutic and analgesic products, NutraPlus India said.

Shares of NutraPlus India were trading at Rs 270 apiece in the afternoon trade on BSE, up 6.47 per cent.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News